Human papilloma virus specific immunogenicity and dysfunction of CD8+ T cells in head and neck cancer (original) (raw)
CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis
Sonia Ledrappier
International Journal of Cancer, 2013
View PDFchevron_right
Antitumor Activity of Human Papillomavirus Type 16 E7-Specific T Cells against Virally Infected Squamous Cell Carcinoma of the Head and Neck
Andreas Albers
Cancer Research, 2005
View PDFchevron_right
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx
Vera Balz
International Journal of Cancer, 2006
View PDFchevron_right
Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium
Jessica Teague
The Journal of Immunology, 2010
View PDFchevron_right
Epithelial expression of human papillomavirus type 16 E7 protein results in peripheral CD8 T-cell suppression mediated by CD4+CD25+ T cells
Graham Leggatt
European Journal of Immunology, 2009
View PDFchevron_right
A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers
Karen Anderson
Journal of Biological Chemistry, 2010
View PDFchevron_right
Effect of Human Papillomavirus-16 Infection on CD8+ T-Cell Recognition of a Wild-Type Sequence p53264–272 Peptide in Patients with Squamous Cell Carcinoma of the Head and Neck
Albert DeLeo
Clinical Cancer Research, 2004
View PDFchevron_right
Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma
Peter Stern
British Journal of Cancer, 2015
View PDFchevron_right
Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8(+) Tumour-infiltrating Lymphocytes and Other Biomarkers in Cancer of Unknown Primary in the Head and Neck Region
Tina Dalianis
Anticancer research, 2017
View PDFchevron_right
Immune Response to HPV16 E6 and E7 Proteins and Patient Outcomes in Head and Neck Cancer
Scott M Langevin
JAMA Oncology, 2017
View PDFchevron_right
Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts
Ekaterina Jordanova
International Journal of Cancer, 2007
View PDFchevron_right
Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and –DP as a restriction element
Gert Fleuren
International Journal of Cancer, 2008
View PDFchevron_right
Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity
Sanjib Chaudhary
JNCI: Journal of the National Cancer Institute, 2018
View PDFchevron_right
Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perform expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells
Stefania Bellone
Clinical Cancer Research, 2001
View PDFchevron_right
A Clinically Translatable Immune-based Classification of HPV-associated Head and Neck Cancer with Implications for Biomarker-Driven Treatment Deintensification and Immunotherapy
Tito Poli
2022
View PDFchevron_right
Immunotherapy of HPV-associated head and neck cancer
stephane HANS
OncoImmunology, 2013
View PDFchevron_right
Intratumoral HPV16-specific T-cells constitute a type 1 oriented tumor microenvironment to improve survival in HPV16-driven oropharyngeal cancer
Marij Welters
Clinical cancer research : an official journal of the American Association for Cancer Research, 2017
View PDFchevron_right
Cytotoxic T-Lymphocyte Responses to Human Papillomavirus Type 16 E5 and E7 Proteins and HLA-A*0201-Restricted T-Cell Peptides in Cervical Cancer Patients
岱瑋 劉
Journal of Virology, 2007
View PDFchevron_right
Immunotherapy targeting HPV 16/18 generates potent immune responses in HPV-Associated Head and Neck Cancer
Mark Esser
Clinical cancer research : an official journal of the American Association for Cancer Research, 2018
View PDFchevron_right
CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia
Maria Moreno
International Journal of Cancer, 2007
View PDFchevron_right
Human Papillomavirus Type 16-Positive Cervical Cancer Is Associated with Impaired CD4+ T-Cell Immunity against Early Antigens E2 and E6
Gert Fleuren
Cancer Research, 2004
View PDFchevron_right
Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells
Antonella Ravaggi
Clinical cancer research : an official journal of the American Association for Cancer Research, 2001
View PDFchevron_right
HPV16 E629-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function
Alison Fiander
International Journal of Cancer, 2008
View PDFchevron_right
Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy
Peter Stern
Therapeutic Advances in Vaccines, 2017
View PDFchevron_right
Studies on human papillomavirus (HPV) 16 E2, E5 and E7 mRNA in HPV-positive tonsillar and base of tongue cancer in relation to clinical outcome and immunological parameters
Tina Dalianis
Oral Oncology, 2015
View PDFchevron_right
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope
Cornelis Melief
Cancer research, 1996
View PDFchevron_right